International Patent: CLINICAL USE OF SBCMA IN CEREBROSPINAL FLUID IN DIAGNOSIS AND MONITORING OF CENTRAL NERVOUS SYSTEM AUTOIMMUNE DISEASES

GENEVA, July 2 -- TONGJI HOSPITAL, TONGJI MEDICAL COLLEGE, HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY filed a patent application (CN2025/073879) for “CLINICAL USE OF SBCMA IN CEREBROSPINAL FLUID IN DIAGNOSIS AND MONITORING OF CENTRAL NERVOUS SYSTEM AUTOIMMUNE DISEASES”. With publication no. WO/2026/129462, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G01N 33/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....